Search

You searched for "tumour"

357 results found

A three-way partnership between Nigeria, Tanzania and Northern Ireland

1 June 2015 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
VISION 2020 LINKS between Western Health and Social Care Trust (WHSCT), Altnagelvin Area Hospital, Northern Ireland with first ECWA Eye Hospital, Kano, Nigeria and now also with Mbeya Referral Hospital (MRH), Tanzania, have been beneficial to all three partners. From...

Immunoglobulin G4-related ophthalmic disease – what is it? (Part 2)

3 April 2023 |
Part 2: Clinical presentation and treatment (see part 1 here) Introduction IgG4-related disease (IgG4-RD) is understood to have a vast clinicopathological spectrum; nearly every organ has had reported involvement. Similarly, IgG4-related ophthalmic disease (IgG4-ROD) is known to affect nearly every...

How to maximise points for your ophthalmology portfolio as a medical student

4 December 2023 | | EYE - General
Ophthalmology is an extremely popular and competitive career option, with one of the highest competition ratios at ST1 level entry (10:1 in 2023) [1]. It is also a highly rewarding speciality, involving: a mixture of medicine and surgery in a...

Thyroid eye disease

22 September 2021 | | EYE - Orbit, EYE - General
Thyroid eye disease (TED) is an autoimmune condition with a spectrum of signs and symptoms, usually associated with Graves’ hyperthyroidism. The diagnosis is based on history and physical examination but there are further investigations that can aid diagnosis if unclear....

Minimally Invasive Glaucoma Surgery: What options are there and when might they be considered?

25 March 2024 | | EYE - Glaucoma
In recent years there has been a rapid expansion in a group of operations termed ‘minimally invasive’ or ‘micro invasive’ glaucoma surgery (MIGS). These options generally offer less significant IOP reduction, but with a more favourable safety profile when compared...

Real-world experience and outcomes of SLT laser used as a first-line treatment in ocular hypertension patients in a United Kingdom National Health Service setting

3 October 2022 |
The management of raised intraocular pressure (IOP) in the context of ocular hypertension (OHT) and primary open angle glaucoma (POAG) remains a major contributor to the workload of ophthalmology units across the UK. Treatment of these conditions has historically centred...

Learnings and trends in the management of open-angle and angle-closure glaucoma

1 August 2017 | | EYE - Glaucoma
To be truly disruptive, newer technologies need to offer a quality of life benefit over medication to a broad population of glaucoma sufferers. Evidence and converging trends in medical and surgical management of glaucoma were explored in counterpoint discussions and...

A closer look at the new wave of glaucoma surgery – radical or old school?

1 October 2016 | | EYE - Glaucoma
Glaucoma is a challenging condition to treat because the exact pathophysiology remains unclear and the only readily modifiable factor is the intraocular pressure (IOP). Additionally, most glaucoma patients are completely asymptomatic, yet are often subjected to lifelong medical therapy. The...

Treatment of diabetic macular oedema

1 June 2014 | | EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is a common complication associated with diabetic retinopathy, and the most common cause of visual impairment in diabetes [1]. With predicted rising levels of diabetes (in England by 2025 the estimated population with diabetes will be...